176 related articles for article (PubMed ID: 25223295)
1. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
[TBL] [Abstract][Full Text] [Related]
2. Salivary proteomics for oral cancer biomarker discovery.
Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
[TBL] [Abstract][Full Text] [Related]
3. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
5. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
[TBL] [Abstract][Full Text] [Related]
6. Serum circulating human mRNA profiling and its utility for oral cancer detection.
Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
[TBL] [Abstract][Full Text] [Related]
7. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
[TBL] [Abstract][Full Text] [Related]
8. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
9. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
10. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
12. Identification of tetranectin as a potential biomarker for metastatic oral cancer.
Arellano-Garcia ME; Li R; Liu X; Xie Y; Yan X; Loo JA; Hu S
Int J Mol Sci; 2010 Sep; 11(9):3106-21. PubMed ID: 20957082
[TBL] [Abstract][Full Text] [Related]
13. Serum HSP90-Alpha and Oral Squamous Cell Carcinoma: A Prospective Biomarker.
Usman M; Ilyas A; Syed B; Hashim Z; Ahmed A; Zarina S
Protein Pept Lett; 2021; 28(10):1157-1163. PubMed ID: 34137356
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis.
Nagata M; Fujita H; Ida H; Hoshina H; Inoue T; Seki Y; Ohnishi M; Ohyama T; Shingaki S; Kaji M; Saku T; Takagi R
Int J Cancer; 2003 Sep; 106(5):683-9. PubMed ID: 12866027
[TBL] [Abstract][Full Text] [Related]
15. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.
Ding L; Hu EL; Xu YJ; Huang XF; Zhang DY; Li B; Hu QG; Ni YH; Hou YY
Tumour Biol; 2015 Apr; 36(4):2523-9. PubMed ID: 25613064
[TBL] [Abstract][Full Text] [Related]
17. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma.
Pasini FS; Maistro S; Snitcovsky I; Barbeta LP; Rotea Mangone FR; Lehn CN; Walder F; Carvalho MB; Brentani MM; Federico MH
Acta Oncol; 2012 Jan; 51(1):77-85. PubMed ID: 21985131
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
[TBL] [Abstract][Full Text] [Related]
19. Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.
Oka R; Nakashiro K; Goda H; Iwamoto K; Tokuzen N; Hamakawa H
Oncotarget; 2016 Jan; 7(4):4882-9. PubMed ID: 26700817
[TBL] [Abstract][Full Text] [Related]
20. Integrated computational screening and liquid biopsy approach to uncover the role of biomarkers for oral cancer lymph node metastasis.
Shaikh S; Yadav DK; Bhadresha K; Rawal RM
Sci Rep; 2023 Aug; 13(1):14033. PubMed ID: 37640804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
